Marking a new beginning in diagnosis of Breast Cancer, South Asia�s first-of-its-kind, Full-Field Digital Mammography with Tomosynthesis (3D) system was inaugurated at Apollo Speciality Cancer Hospitals, Chennai by Dr. Prathap C Reddy, Chairman, Apollo Hospitals Group today, in the presence of Mr. Jack Cumming, Chairman, Hologic Inc., USA and Dr. G S K Velu, Founder & Managing Director, Trivitron Healthcare.
Digital Mammography with Tomosynthesis (3D) is the latest technology for breast cancer. This device Breast Tomosynthesis is a 3-dimensional imaging technology that involves acquiring images of a stationary compressed breast at multiple angles during a short scan. The individual images are then reconstructed into a series of thin high resolution slices that can be displayed individually or in a dynamic cin� mode. Digital breast Tomosynthesis offers a number of exciting opportunities including the possibility of reduced breast compression, improved diagnostic and screening accuracy, 3-D lesion localization, and contrast-enhanced 3-D imaging.
Speaking at the inauguration, Dr. Prathap C Reddy, Chairman, Apollo Hospitals Group said, �Breast cancer is the one of the commonest malignancies afflicting women. According to recent research data, over 16 percent of Indian women in the age group of 40-60 years face a potential risk of breast cancer. Beyond this, delayed detection can result in 1 of every 22 women actually developing breast cancer. As the pioneering healthcare leader, Apollo Speciality Cancer Hospitals is committed to fight the menace of cancer. Now, the contemporary Digital Mammography with Tomosynthesis (3D) technology at Apollo Speciality Cancer Hospitals Chennai, the first-of-its-kind in South Asia, will enable faster and accurate Stereotactic biopsies. This technology needs shorter examination time for diagnosis of breast cancer and also significantly improves patient comfort and convenience and will certainly motivate early detection�.